Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Modal balancing

Modal balancing is based on the fact that a flexible rotor may be balanced by eliminating the effect of the unbalance distribution in a mode-by-mode sequence. Typical principal modes of a symmetric, uniform shaft are shown... [Pg.592]

The A-plane is based on the concepts of the modal technique. From Equation (17-5), there are N principal modes that need to be zero for the perfect balance of a rotor, which runs through Mh critical speed. Thus, A-planes located at the peaks of the principal modes will be enough for cancelling these modes. From the point of view of residual forces and moments at the support bearings, (N + 2)-planes are better than A-planes. [Pg.596]

An inhibitor that binds exclusively to the ES complex, or a subsequent species, with little or no affinity for the free enzyme is referred to as uncompetitive. Inhibitors of this modality require the prior formation of the ES complex for binding and inhibition. Hence these inhibitors affect the steps in catalysis subsequent to initial substrate binding that is, they affect the ES —> ES1 step. One might then expect that these inhibitors would exclusively affect the apparent value of Vm and not influence the value of KM. This, however, is incorrect. Recall, as illustrated in Figure 3.1, that the formation of the ESI ternary complex represents a thermodynamic cycle between the ES, El, and ESI states. Hence the augmentation of the affinity of an uncompetitive inhibitor that accompanies ES complex formation must be balanced by an equal augmentation of substrate affinity for the El complex. The result of this is that the apparent values of both Vmax and Ku decrease with increasing concentrations of an uncompetitive inhibitor (Table 3.3). The velocity equation for uncompetitive inhibition is as follows ... [Pg.67]

Several models for diffusive transport in and among minerals have been discussed in the literature one is the fast grain boundary (FGB) model of Eiler et al. (1992, 1993). The FGB model considers the effects of diffusion between non-adjacent grains and shows that, when mass balance terms are included, closure temperatures become a strong function of both the modal abundances of constituent minerals and the differences in diffusion coefficients among all coexisting minerals. [Pg.17]

Mass balance effects can cause isotope fractionations because modal proportions of substances can change during a chemical reaction. They are especially important for elements in situations where these coexist in molecules of reduced and oxidized compounds. Conservation of mass in an n component system can be described by... [Pg.35]

Diffusion modeling, on the other hand, also predicts that accnrate temperatnres can be obtained from refractory accessory minerals, if they occur in a rock that is modally dominated by a readily exchangeable mineral (Valley 2001). The basis of this approach is that the accessory mineral preserves the isotope composition from crystallization becanse of slow diffnsion while the dominant mineral preserves its isotope composition by mass balance because there are no other snfficiently abnn-dant exchangeable phases. [Pg.225]

As many as 10% of children have a medication-responsive psychiatric disorder (Riddle et ah, 1998) and there has been a dramatic increase in the use of psychotropic medication to treat mental disorders in youth (Rappley et ah, 1999). Multiple factors account for this increase, including scientific advances in fields such as epidemiology, nosology, neuroscience, drug development, and clinical measurements, and efforts to educate the public about the benefits of early, effective treatment. Despite large gaps between research and practice, many medications are used in children on the basis of a small amount of scientific data. Factors that contribute to this situation are societal desires for rapid, effective treatment, acceptance of medication as a therapeutic modality, and a reimbursement climate in which there is increased pressure for brief treatment. Clearly there is a need to balance clinical and administrative pressures with a resort to treatment based on the best available data. [Pg.391]

The application areas of bimodal polyethylenes are the same as for corresponding uni-modal resins. However, improved product property combinations, such as stiffness-impact balance, result in products with higher performance. For example, without bimodal polyethylene and control over the MWD and comonomer incorporation, development of HDPE pipe materials with higher pressure classification would not have been possible [15, 16]. Another new opportunity is material reduction (source reduction) without compromising the properties of the ready-made plastic products. Depending on the end use, e.g. in film application a thickness reduction of 10-30% is possible. [Pg.23]

This chapter will review the relative contributions of exercise and food intake to changes in body weight and more specifically body composition. The emphasis of this chapter is on exercise as a modality for fat reduction and fat-free weight maintenance with the focus on aerobic exercise which has greater potential to modify body composition due to larger effects on energy balance. The first section reviews the effects of aerobic exercise on body composition in humans. The second section addresses techniques for measurement of body composition and limitations of these measurements in humans. The third section examines the use of experimental animals for studies of exercise and body composition, and the fourth section examines the interactions of diet and exercise. [Pg.126]

Detailed studies of the incompatible trace-element budget of mantle xenoliths illustrate the problems. Mass balance studies that use modal analyses and mineral compositions to calculate... [Pg.902]

New modalities in genomics, proteomics, and imaging have allowed monitoring of these effects and provide new directives for the future. All together, we provide a balanced review for the role of immunity in the pathogenesis of PD and ALS and the means to modulate it for therapeutic benefit. The strengths and concerns for each of these approaches are discussed. [Pg.641]

These models require information about mean velocity and the turbulence field within the stirred vessels. Computational flow models can be developed to provide such fluid dynamic information required by the reactor models. Although in principle, it is possible to solve the population balance model equations within the CFM framework, a simplified compartment-mixing model may be adequate to simulate an industrial reactor. In this approach, a CFD model is developed to establish the relationship between reactor hardware and the resulting fluid dynamics. This information is used by a relatively simple, compartment-mixing model coupled with a population balance model (Vivaldo-Lima et al., 1998). The approach is shown schematically in Fig. 9.2. Detailed polymerization kinetics can be included. Vivaldo-Lima et a/. (1998) have successfully used such an approach to predict particle size distribution (PSD) of the product polymer. Their two-compartment model was able to capture the bi-modal behavior observed in the experimental PSD data. After adequate validation, such a computational model can be used to optimize reactor configuration and operation to enhance reactor performance. [Pg.249]

Some of the more common performance measurement systems used to assess pharmaceutical outcomes include report cards, balanced scorecards, clinical value compasses, profiling, performance-based evaluation systems, and others. The goals of pharmaceutical performance measurement systems are to 1) compare treatment modalities fairly 2) recognize and promote good care 3) identify and eliminate substandard care and 4) improve the level of care overall.Because performance measures can include data over the course of treatment, the outcomes of alternative therapies and practices may be detected. The end goal of any performance measurement system should not be cost containment only improving patient outcomes must be a primary concern, keeping in mind the cost effectiveness of the therapy and sustainability of the system. [Pg.702]

Quality patient care must not be compromised while attempting to contain costs. The products and services delivered by today s health professionals should demonstrate pharmacoeconomic value, that is, a balance of economic, humanistic, and clinical outcomes. Pharmacoeconomics can provide the systematic means for this quantification. This chapter discusses the principles and methods of pharmacoeconomics and how they can be applied to clinical pharmacy practice and thereby how they can assist in the valuation of pharmacotherapy and other modalities of treatment in clinical practice. [Pg.1]

Major differences exist between the metabolic, fluid, and electrolyte management of patients with acute versus chronic kidney disease (CKD). For example, positive nitrogen balance is more difficult to achieve in patients with acute renal failure (ARF) due to the increased rate of protein catabolism. Additionally, patients with acute renal failure are more likely to develop hyperglycemia during nutritional support and frequently are dialyzed by modalities that are not used commonly for the patient with end-stage kidney disease (ESKD). Because of these differences, the nutritional management of patients with ARF is discussed separately. [Pg.2636]


See other pages where Modal balancing is mentioned: [Pg.808]    [Pg.106]    [Pg.169]    [Pg.808]    [Pg.106]    [Pg.169]    [Pg.1535]    [Pg.590]    [Pg.592]    [Pg.594]    [Pg.594]    [Pg.594]    [Pg.290]    [Pg.521]    [Pg.44]    [Pg.59]    [Pg.77]    [Pg.94]    [Pg.96]    [Pg.287]    [Pg.343]    [Pg.6]    [Pg.707]    [Pg.546]    [Pg.215]    [Pg.230]    [Pg.268]    [Pg.363]    [Pg.1822]    [Pg.246]    [Pg.885]    [Pg.946]    [Pg.1505]    [Pg.1506]    [Pg.1507]    [Pg.1520]    [Pg.67]    [Pg.174]   


SEARCH



© 2024 chempedia.info